Lipoprotein (a): implication in atherothrombosis.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Atherosclerosis

• Publication date

  1994-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0021-9150(94)05385-VPMID 7857388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural domains of apolipoprotein(a) and its interaction with apolipoprotein B-100 in the lipoprotein(a) particle.

  1994cited by this paper
• Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?

  1993cited by this paper
• Molecular definition of the extreme size polymorphism in apolipoprotein(a).

  1993cited by this paper
• Physical properties of recombinant apolipoprotein(a) and its association with LDL to form an LP(a)-like complex.

  1993cited by this paper
• Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis

  1993cited by this paper
• The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

  1993cited by this paper
• Apolipoprotein (a): A comparison of isoforms identified by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis or by sodium dodecyl sulfate‐agarose gel electrophoresis

  1993cited by this paper
• Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

  1992cited by this paper
• Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

  1992cited by this paper
• Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group.

  1992cited by this paper
• Oxidative modification of lipoprotein(a) and the effect of β-carotene

  1992cited by this paper
• Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.

  1992cited by this paper
• Oxidative modification of lipoprotein(a) and the effect of beta-carotene.

  1992cited by this paper
• The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

  1992cited by this paper
• Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.

  1992cited by this paper
• Expressed hypervariable polymorphism of apolipoprotein (a).

  1991cited by this paper
• Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

  1991cited by this paper
• Lipoprotein (a) in the arterial wall

  1991cited by this paper
• Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

  1991cited by this paper
• Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins.

  1991cited by this paper
• Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu.

  1991cited by this paper
• Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.

  1991cited by this paper
• Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.

  1991cited by this paper
• Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)).

  1990cited by this paper
• Lipoprotein (a). Heterogeneity and biological relevance.

  1990cited by this paper
• Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a].

  1990cited by this paper
• Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a].

  1990cited by this paper
• Lipoprotein(a). A unique risk factor for atherothrombotic disease.

  1990cited by this paper
• Lipoprotein(a), fibrin binding, and plasminogen activation.

  1990cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Human Plasma Lipoproteins

  1989cited by this paper
• Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

  1989cited by this paper
• Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

  1989cited by this paper
• A potential basis for the thrombotic risks associated with lipoprotein(a)

  1989cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

  1987cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.

  1986cited by this paper
• Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.

  1984cited by this paper
• Human plasma lipoprotein [a]. Structural properties.

  1983cited by this paper
• Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma.

  1972cited by this paper

• Lipoprotein(a) and cardiovascular disease.

  2024cites this paper
• Development and Validation of a New Nomogram Model for Predicting Acute Ischemic Stroke in Elderly Patients with Non-Valvular Atrial Fibrillation: A Single-Center Cross-Sectional Study

  2024cites this paper
• Interplay Among Lipoproteins, Endothelial Cells and Platelets

  2023cites this paper
• Relationship between lipoproteins, thrombosis, and atrial fibrillation

  2021cites this paper
• Cardiovascular disease-related risk factors in perimenopausal women

  2020cites this paper
• A study on lipoprotein(a) in health and type-2 diabetes mellitus

  2017cites this paper
• A study on lipoprotein(a) in health and type-2 diabetes mellitus

  2017cites this paper
• Lipoprotein(a) in Cardiovascular Diseases

  2012cites this paper
• Important Considerations for Treatment with Dietary Supplement versus Prescription Niacin Products

  2011cites this paper
• Do C-Reactive Protein and Lipoprotein (a) Have Different Impacts on the Severity of Coronary Artery Disease in Diabetic and Non-Diabetic Patients?

  2008cites this paper
• Lipoprotein (a) in patients with spontaneous venous thromboembolism.

  2007cites this paper
• Lipoproteins, Vascular-Related Genetic Factors, and Human Longevity

  2007cites this paper
• Determinants of risk factors of atherosclerosis in the postinfarction period: The Tallinn MI Study

  2006cites this paper
• The Antioxidant Hypothesis

  2006cites this paper
• Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.

  2004cites this paper
• El fenotipo de lipoproteína(a): ¿un marcador genético de enfermedad coronaria?

  2004cites this paper
• Atherogenesis and vascular calcification in mice expressing the human LPA gene.

  2004cites this paper
• Lipoprotein(a)-Associated PAF-Acetylhydrolase Activity in Patients with Coronary Artery Disease

  2003cites this paper
• Lipoprotein(a) in the elderly: beyond atherosclerosis.

  2002cites this paper
• Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging).

  2002cites this paper
• Serum Lipoprotein(a) Concentrations and Apolipoprotein(a) Isoforms: Association with the Severity of Clinical Presentation in Patients with Coronary Heart Disease

  2001cites this paper
• Homocysteine and Hemostatic Risk Factors in Atherosclerosis in Patients with Primary Hypertension

  2001cites this paper
• orthotopic heart transplantation

  2000cites this paper
• Changes in lipoprotein(a) concentration after orthotopic heart transplantation.

  2000cites this paper
• Lipoprotein (a) and stroke

  2000cites this paper
• Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels.

  2000cites this paper
• Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.

  1999cites this paper
• Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians.

  1999cites this paper
• Relationships between apolipoprotein(a) phenotype and increase of lipoprotein(a) by troglitazone.

  1999cites this paper
• Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

  1998cites this paper
• Biologic markers as predictors of cardiovascular disease.

  1998cites this paper
• Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis.

  1998cites this paper
• Lipoprotein(a) levels in liver diseases and changes of lipoprotein(a) levels before and after interferon therapy in patients with chronic hepatitis-C

  1997cites this paper
• Whither Lipoprotein(a): Is This Lipid Subclass a Causative or Predictive Factor in Diabetic Macrovascular Disease?

  1997cites this paper
• Plasma and cerebrospinal fluid activities of tissue plasminogen activator, urokinase and plasminogen activator inhibitor-1 in multiple sclerosis

  1997cites this paper
• Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells

  1997cites this paper
• Whither Lipoprotein(a): Is This Lipid Subclass a Causative or Predictive Factor in Diabetic Macrovascular Disease?

  1997cites this paper
• Increase of lipoprotein (a) with troglitazone.

  1997cites this paper
• Chapter 11. Atherothrombogenesis

  1996cites this paper
• Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.

  1996cites this paper
• Effect of antioxidants alone and in combination with monounsaturated fatty acid-enriched diets on lipoprotein oxidation.

  1996cites this paper
• Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study.

  1995cites this paper
• Lipoprotein (a) and coronary heart disease.

  1995cites this paper